EACTS/ESC joint statement on the revision of the Guidelines on Myocardial Revascularization
Sophia Antipolis & Windsor, 6 October 2020: The European Society of Cardiology (ESC) and the European Association for Cardiothoracic Surgery (EACTS) have agreed to collaborate in reviewing the most up-to-date evidence for the treatment of patients with left main coronary artery stenosis as soon as it is available. In particular, the organisations wish to review their joint guidelines1 in the light of emerging, longer term outcome data from the trials of CABG vs PCI, and an independent patient-level meta-analysis of these trials that is currently under way.
The two organisations will establish a robust and transparent process to review this new evidence.
In the meantime, ESC and EACTS recommend that treatment decisions for individual patients take into account all available published information. As stated in the ESC/EACTS Guidelines on Myocardial Revascularization, a discussion within the heart team and with the patient should be the basis of all treatment decisions.
The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.
The mission of the Association is to advance education in the field of cardiac, thoracic and vascular interventions; and promote research into cardiovascular and thoracic physiology, pathology and therapy, with the aim to correlate and disseminate the results for the public benefit.